Cargando…

Evaluation of three commercially-available chikungunya virus immunoglobulin G immunoassays

The emergence of chikungunya virus in the Americas means the affected population is at risk of developing severe, chronic, rheumatologic disease, even months after acute infection. Accurate diagnostic methods for past infections are essential for differential diagnosis and consequence management. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Salazar, Pablo M, Marie Valadere, Anne, Goodman, Christin H, Johnson, Barbara W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Organización Panamericana de la Salud 2017
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612722/ https://www.ncbi.nlm.nih.gov/pubmed/28902275 http://dx.doi.org/10.26633/RPSP.2017.62

Ejemplares similares

Evaluation of Commercially Available Chikungunya Virus Immunoglobulin M Detection Assays
por: Johnson, Barbara W., et al.
Publicado: (2016)

Transcontinental Movement of Asian Genotype Chikungunya Virus
por: Lanciotti, Robert S., et al.
Publicado: (2014)

Evaluation of 5 Commercially Available Zika Virus Immunoassays
por: Safronetz, David, et al.
Publicado: (2017)

Evaluation of Commercially Available Serologic Diagnostic Tests for Chikungunya Virus
por: Prat, Christine M., et al.
Publicado: (2014)

Evaluation of a Newly Developed Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect IgG and IgM Antibodies to Chikungunya Virus
por: Lee, Hyeyoung, et al.
Publicado: (2020)

Early Appearance of Neutralizing Immunoglobulin G3 Antibodies Is Associated With Chikungunya Virus Clearance and Long-term Clinical Protection
por: Kam, Yiu-Wing, et al.
Publicado: (2012)

Evaluation of Commercially Available Anti–Dengue Virus Immunoglobulin M Tests
por: Hunsperger, Elizabeth A., et al.
Publicado: (2009)

Validation of a commercially available SARS-CoV-2 serological immunoassay
por: Meyer, B., et al.
Publicado: (2020)

Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays
por: Weidner, Lisa, et al.
Publicado: (2020)

Validation of dried blood spot sample modifications to two commercially available COVID-19 IgG antibody immunoassays
por: Zava, Theodore T, et al.
Publicado: (2020)

Susceptibility of Chikungunya Virus to Inactivation by Heat and Commercially and World Health Organization-Recommended Biocides
por: Franz, Sergej, et al.
Publicado: (2018)

Comparison of 3 Automated Immunoassays for Detection of Anti-Hepatitis A Virus Immunoglobulin M in a Tertiary Care Hospital
por: Park, Hyewon, et al.
Publicado: (2013)

Disparity in cholecalciferol content of commercial preparations available in India
por: Khadgawat, Rajesh, et al.
Publicado: (2013)

Clinical Laboratory Utility of a Humanized Antibody in Commercially Available Enzyme Immunoassays for Coccidioidomycosis
por: Grill, Francisca J., et al.
Publicado: (2022)

Comparative Evaluation of Four Commercially Available Immunoassays for Therapeutic Drug Monitoring of Infliximab and Adalimumab
por: Rissel, Florian, et al.
Publicado: (2023)

Understanding the evolution and spread of chikungunya virus in the Americas using complete genome sequences
por: Sahadeo, N. S. D., et al.
Publicado: (2017)

A comparison of SARS-CoV-2 nucleocapsid and spike antibody detection using three commercially available automated immunoassays
por: Poore, Brad, et al.
Publicado: (2021)

Multi-laboratory comparison of three commercially available Zika IgM enzyme-linked immunosorbent assays
por: Basile, Alison Jane, et al.
Publicado: (2018)

Hilar cholangiocarcinoma associated with immunoglobulin G4‐positive plasma cells and elevated serum immunoglobulin G4 levels
por: Azeem, Nabeel, et al.
Publicado: (2018)

The arrival of SARS-CoV-2–neutralizing antibodies in a currently available commercial immunoglobulin
por: Miller, Aaron L., et al.
Publicado: (2022)

Chikungunya virus iridocyclitis in Fuchs’ heterochromic iridocyclitis
por: Mahendradas, Padmamalini, et al.
Publicado: (2010)

Two Commercially Available Blood-Stabilization Reagents Serve as Potent Inactivators of Coronaviruses
por: O’Connor, Joseph J., et al.
Publicado: (2023)

Agreement between commercially available ELISA and in-house Luminex SARS-CoV-2 antibody immunoassays
por: Santano, Rebeca, et al.
Publicado: (2021)

Detection of virus-specific intrathecally synthesised immunoglobulin G with a fully automated enzyme immunoassay system
por: Schubert, Jörg, et al.
Publicado: (2007)

Development and evaluation of antibody-capture immunoassays for detection of Lassa virus nucleoprotein-specific immunoglobulin M and G
por: Gabriel, Martin, et al.
Publicado: (2018)

Serological Detection of SARS-CoV-2 IgG Using Commercially Available Enzyme Immunoassays on Dried Blood Spots Collected from Patients
por: Walker, Gregory J., et al.
Publicado: (2021)

Chikungunya virus outbreak in Sint Maarten, 2013–2014
por: Henry, Maria, et al.
Publicado: (2017)

Immunoglobulin G subclass switching impacts sensitivity of an immunoassay targeting Francisella tularensis lipopolysaccharide
por: Nualnoi, Teerapat, et al.
Publicado: (2018)

Inactivation of SARS-CoV-2 by commercially available alcohol-based hand sanitizers
por: Leslie, Rachel A., et al.
Publicado: (2021)

Optimization of commercially available Zika virus antibodies for use in a laboratory‐developed immunohistochemical assay
por: Bollweg, Brigid C, et al.
Publicado: (2017)

Comparison of Two Commercially Available Immunoassays for the Measurement of Bovine Cardiac Troponin I in Cattle With Induced Myocardial Injury
por: Smith, Joe S., et al.
Publicado: (2020)

Quantitative immunoassay for mink immunoglobulin in serum and milk
por: Mathiesen, Ronja, et al.
Publicado: (2018)

Commercially Available Essential Oil Formulas as Repellents Against the Stored-Product Pest Alphitobius diaperinus
por: Francikowski, Jacek, et al.
Publicado: (2019)

An extension to: Systematic assessment of commercially available low-input miRNA library preparation kits
por: Heinicke, Fatima, et al.
Publicado: (2020)

Performance of Commercially Available Rapid Serological Assays for the Detection of SARS-CoV-2 Antibodies
por: Hashem, Anwar M., et al.
Publicado: (2020)

Comparison of Allergenic Properties among Commercially Available House Dust Mite Allergen Extracts in Korea
por: Kim, Ji Tae, et al.
Publicado: (2021)

Chikungunya Virus Replication in Salivary Glands of the Mosquito Aedes albopictus
por: Vega-Rúa, Anubis, et al.
Publicado: (2015)

A Case of Chikungunya Virus Induced Arthralgia Responsive to Colchicine
por: Redel, Henry
Publicado: (2016)

Identification of a Continuously Stable and Commercially Available Cell Line for the Identification of Infectious African Swine Fever Virus in Clinical Samples
por: Rai, Ayushi, et al.
Publicado: (2020)

Development of Nucleic Acid Lateral Flow Immunoassay for Rapid and Accurate Detection of Chikungunya Virus in Indonesia
por: Ajie, Mandala, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4qjnfaf5949sfl07c4q6mg0632